Smith & Nephew retains membership of World Dow Jones Sustainability Indices for fourteenth consecutive year
16 September 2016
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, is proud to announce that it has retained its position as an index component on the Dow Jones Sustainability Indices (DJSI).
Since 1999, the DJSI tracks the financial performance of the leading sustainability-driven companies worldwide based on an analysis of financially relevant economic, environmental, and social factors. Smith & Nephew is included in both the 2016 DJSI World and DJSI Europe Indices. Smith & Nephew has now been a member of DJSI World since 2002 and a member of DJSI Europe since 2001.
In the Healthcare Equipment and Supplies sector, Smith & Nephew is one of only seven members of the DJSI World Index and one of just three members for DJSI Europe. Smith & Nephew scored highly in Climate Strategy, Occupational Health and Safety, Social Reporting and was awarded a perfect score in the Environmental Reporting category, illustrating the company’s continued excellence in sustainable operations.
Olivier Bohuon, Chief Executive Officer of Smith & Nephew, said:
“We are firmly committed to making a meaningful contribution across all three pillars of sustainability – social, environmental and economic. Our emphasis is on delivering positive outcomes that advance the long-term prospects for our business everywhere we operate. We will continue to strive to be a responsible business that sets an example for others. ”
Media
Charles Reynolds, Corporate Communications
Smith & Nephew
+44 (0)20 7401 7646
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management,Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2015 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
For more information about Smith & Nephew, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew’s most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew’s expectations.
